Y. Deeni
发表
Hilal S. Khalil,
J. Bown,
D. Harrison,
2014,
Cells.
Hilal S. Khalil,
J. Bown,
D. Harrison,
2015,
Journal of biotechnology.
S. Cameron,
A. Spiers,
S. Hapca,
2017
.
C. Wilding,
P. Collier,
Y. Deeni,
2014
.
W. E. Stephens,
A. Scaloni,
Y. Deeni,
2020,
RSC advances.
R. Agu,
G. Walker,
Y. Deeni,
2016
.
Gillian Smith,
C. Wolf,
S. Ibbotson,
2003,
The Lancet.
E. Igumbor,
C. Ihekweazu,
C. King,
2022,
PLOS global public health.
Y. Deeni,
H. Abdu,
Y. Abdussalam,
2018
.
E. Igumbor,
Y. Deeni,
C. Ochu,
2020,
medRxiv.
Cloning Of Anopheles Gambiae CYP6M2 Gene Promoter And Construction Of Its Luciferase Reporter System
C. Wilding,
P. Collier,
Y. Deeni,
2014
.
Y. Deeni,
B. R. Mohammed,
Y. M. Abdulsalam,
2015
.
A. Spiers,
S. Hapca,
Y. Deeni,
2018,
FEMS microbiology letters.
I. Mustapha,
Y. Deeni,
A. Uba,
2020
.
Hilal S. Khalil,
J. Bown,
D. Harrison,
2018
.
A. Spiers,
A. Koza,
S. Hapca,
2017,
Research in microbiology.
C. Wolf,
B. Burchell,
T. Friedberg,
2001,
The Biochemical journal.
C. Wolf,
B. Burchell,
T. Friedberg,
2022
.
Y. Deeni,
A. Imam,
2015
.
R. Agu,
G. Walker,
Y. Deeni,
2019
.
E. Igumbor,
Y. Deeni,
M. Imam,
2022,
bioRxiv.
E. Igumbor,
C. Ihekweazu,
E. Tobin,
2021,
BMJ Global Health.
Susan Stepney,
Adam T. Sampson,
Mark Shovman,
2012,
Current drug targets.
Y. Deeni,
H. Hussain,
1991,
Journal of ethnopharmacology.
Y. Deeni,
H. Hussain,
1991
.
Y. Deeni,
N. Sadiq,
2002,
Journal of ethnopharmacology.
Y. Deeni,
H. Hussain,
1994
.
R. Agu,
G. Walker,
Y. Deeni,
2013
.
S. Langdon,
Y. Deeni,
P. Paramasivan,
2019,
Cancer drug resistance.
Hilal S. Khalil,
J. Bown,
S. Langdon,
2017,
Oxidative medicine and cellular longevity.
T. Beccari,
M. Maffia,
M. Viola-Magni,
2014
.
Hilal S. Khalil,
J. Bown,
D. Harrison,
2016,
Oncotarget.
C. Wilding,
P. Collier,
Y. Deeni,
2014
.
Habibu U. Abdu,
Yayo A. Manu,
Yusuf Y. Deeni,
2017
.
A. Spiers,
Y. Deeni,
H. Abdu,
2014
.
A. Spiers,
S. Hapca,
Y. Deeni,
2015,
FEMS microbiology ecology.
A. Spiers,
A. Koza,
Y. Deeni,
2013
.
R. Agu,
G. Walker,
Y. Deeni,
2015
.
Hilal S. Khalil,
J. Bown,
S. Langdon,
2015,
Oxidative medicine and cellular longevity.
Hilal S. Khalil,
J. Bown,
D. Harrison,
2013
.
S. Langdon,
Y. Deeni,
P. Paramasivan,
2021,
Exploration of targeted anti-tumor therapy.
NRF 2 inhibition causes repression of ATM and ATR expression leading to aberrant DNA Damage Response
Hilal S. Khalil,
Y. Deeni,
2015
.
E. Igumbor,
Y. Deeni,
M. Imam,
2022,
bioRxiv.
Gillian Smith,
C. Wolf,
S. Ibbotson,
2013,
PloS one.
Graeme M. Walker,
Joseph C. Akunna,
David J. Blackwood,
2010
.
Y. Deeni,
A. Imam,
2016
.
M. Wilkie,
C. Wolf,
S. Ibbotson,
2007,
The British journal of dermatology.
A. Spiers,
S. Hapca,
Y. Deeni,
2015,
Letters in applied microbiology.
Y. Deeni,
I. S. Ndams,
I. Nock,
2017,
MalariaWorld journal.
Hilal S. Khalil,
Y. Deeni,
2015
.
C. Wolf,
M. Paine,
S. Clarke,
2001,
Archives of biochemistry and biophysics.
R. Agu,
G. Walker,
Y. Deeni,
2015
.
A. Spiers,
S. Hapca,
Y. Deeni,
2015,
FEMS microbiology ecology.
Deeni,
S. Langdon,
Y. Deeni,
2021,
Exploration of targeted anti-tumor therapy.
Adam T. Sampson,
Ye Li,
James Bown,
2015,
Natural Computing.
E. Igumbor,
Y. Deeni,
M. Imam,
2023,
Frontiers in cellular and infection microbiology.
A. Spiers,
S. Hapca,
Y. Deeni,
2015,
Letters in applied microbiology.